Skip to main content
All lobbying filings

TROUTMAN STRATEGIES

Lobbying for MURAL HEALTH · Clinical trial participant payment and management technology platform.

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 17, 2025
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
Pennsylvania

Official filing document

 Lobbyists on this filing 4
  • LINDSAY JORDAN AUSTIN
    Previously held: Legislative Assistant, Rep. Lynn Westmoreland
  • TOM TILTON
    Previously held: Legislative Assistant, Rep. Betty Sutton
  • CHRISTOPHER BAXTER
    Previously held: Research Assistant, Senator Bob Menendez
  • RYAN DIFFLEY
    Previously held: Legislative Assistant, Rep. Robert Aderholt

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • Internal Revenue Service (IRS)
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 1
  • HR 4184
    To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial particip…
 Lobbying activity 3
Medical/Disease Research/Clinical Labs

Issues related to taxing payments and reimbursements to participants in clinical trials. H. R. 4184 To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.

Health Issues

Legislative monitoring and congressional outreach relating to the weather enterprise and safety and emergency preparedness.

Taxation/Internal Revenue Code

Issues related to taxing payments and reimbursements to participants in clinical trials. H. R. 4184 To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem